ZA71438B - New 1,4-dihydropyridine derivatives - Google Patents

New 1,4-dihydropyridine derivatives

Info

Publication number
ZA71438B
ZA71438B ZA710438A ZA71438A ZA71438B ZA 71438 B ZA71438 B ZA 71438B ZA 710438 A ZA710438 A ZA 710438A ZA 71438 A ZA71438 A ZA 71438A ZA 71438 B ZA71438 B ZA 71438B
Authority
ZA
South Africa
Prior art keywords
new
dihydropyridine derivatives
dihydropyridine
derivatives
Prior art date
Application number
ZA710438A
Other languages
English (en)
Inventor
F Bossert
W Water
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA71438B publication Critical patent/ZA71438B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
ZA710438A 1970-02-05 1971-01-22 New 1,4-dihydropyridine derivatives ZA71438B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2005116A DE2005116C3 (de) 1970-02-05 1970-02-05 Symmetrische 1,4-Dihydropyridin-3,5-dicarbonsäureester

Publications (1)

Publication Number Publication Date
ZA71438B true ZA71438B (en) 1971-10-27

Family

ID=5761434

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA710438A ZA71438B (en) 1970-02-05 1971-01-22 New 1,4-dihydropyridine derivatives

Country Status (17)

Country Link
US (1) US4048171A (ja)
JP (1) JPS5550021B1 (ja)
AT (1) AT302302B (ja)
BE (1) BE762580A (ja)
CA (1) CA944768A (ja)
CH (1) CH553780A (ja)
CS (1) CS161771B2 (ja)
DE (1) DE2005116C3 (ja)
DK (1) DK135282C (ja)
ES (1) ES387973A1 (ja)
FR (1) FR2150555B1 (ja)
GB (2) GB1328479A (ja)
IE (1) IE34896B1 (ja)
IL (1) IL36018A0 (ja)
NL (1) NL171580C (ja)
YU (1) YU18471A (ja)
ZA (1) ZA71438B (ja)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1430961A (en) * 1972-01-22 1976-04-07 Yamanouchi Pharma Co Ltd 1-substituted-1,4-dihyddrypyridine derivatives
GB1409865A (en) * 1973-02-13 1975-10-15 Science Union & Cie Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
DE2349538C2 (de) * 1973-10-02 1982-08-26 Ordena trudovogo krasnogo znameni institut organičeskogo sinteza Akademii Nauk Latvijskoj SSR, Riga Arzneimittel zur Behandlung von Lebererkrankungen
FR2320750A1 (fr) * 1975-08-12 1977-03-11 Hexachimie Dihydro-1,4 pyridines et leur application therapeutique
DE2844130A1 (de) * 1977-10-14 1979-04-26 Labaz Neue dihydropyridine und deren verwendung
FR2405937A1 (fr) * 1977-10-14 1979-05-11 Labaz Nouveaux derives de dihydropyridine, leur procede de preparation et leur application
DE3021958A1 (de) * 1980-06-12 1981-12-24 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
DE3244178A1 (de) * 1982-11-30 1984-05-30 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3247118A1 (de) * 1982-12-20 1984-06-20 Cassella Ag, 6000 Frankfurt Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4520131A (en) * 1983-03-03 1985-05-28 Usv Pharmaceutical Antihypertensive N-substituted 1,4-dihydropyridines
DE3410645A1 (de) * 1984-03-23 1985-09-26 Bayer Ag, 5090 Leverkusen L-alkylsubstituierte 1,4-dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US4672068A (en) * 1984-05-04 1987-06-09 Fujirebio Kabushiki Kaisha Antihypertensive 1,4-dihydropyridines having a conjugated ester
US4683234A (en) * 1984-05-19 1987-07-28 Suntory Limited 2,6-Dimethyl-3N,5-disubstituted-4-(substituted phenyl)3,4-dihydropyrimidine compounds and a method for treating disorders of cardiocircular system
DE3432563A1 (de) * 1984-09-05 1986-03-13 Bayer Ag, 5090 Leverkusen Neue pyridylethyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimittel
US4728652A (en) * 1985-05-20 1988-03-01 E. R. Squibb & Sons, Inc. 2-substituted thio or oxy-4-aryl or heterocyclo-5-carboxy-1,4-dihydropyrimidines, composition containing them, and method of using them to reduce blood pressure
US5202330A (en) * 1985-06-03 1993-04-13 E. R. Squibb & Sons, Inc. 2-thio or oxo-4-aryl or heterocyclo-1,5(2H)-pyrimidinedicarboxylic acid diesters and 3-acyl-5-pyrimidinecarboxylic acids and esters
DE3677319D1 (de) * 1985-10-22 1991-03-07 Sanwa Kagaku Kenkyusho Co Pharmazeutische 1,4-dihydropyridinderivate, ihre salze und herstellung.
US4771057A (en) * 1986-02-03 1988-09-13 University Of Alberta Reduced pyridyl derivatives with cardiovascular regulating properties
JPH0688973B2 (ja) * 1987-03-12 1994-11-09 京都薬品工業株式会社 １，４−ジヒドロピリジン誘導体
US4753946A (en) * 1987-04-08 1988-06-28 E. R. Squibb & Sons, Inc. Pyrimidinecarboxylic acid derivatives
US5216172A (en) * 1988-02-24 1993-06-01 Ajinomoto Co., Inc. 1,4-dihydropyridine-4-aryl-2,6-dimethyl-3,5-dicarboxylates useful as agents against drug resistant tumor cells
EP0330470A3 (en) * 1988-02-24 1992-01-02 Ajinomoto Co., Inc. 1,4-dihydropyridine derivatives useful against tumour cells
JP4431638B2 (ja) * 1996-01-29 2010-03-17 アメリカ合衆国 ジヒドロピリジン―、ピリジン―、ベンゾピラン―オン―およびトリアゾロキナゾリン誘導体、それらの製造およびそれらのアデノシン受容体アンタゴニストとしての用途
WO1997037667A1 (en) 1996-04-10 1997-10-16 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of an a1 adenosine receptor agonist to treat cerebral ischaemia
CA2336967C (en) 1998-07-10 2010-06-29 The United States Of America, Represented By The Secretary, Department Of Health And Human Services A3 adenosine receptor antagonists
WO2001051490A1 (en) 2000-01-14 2001-07-19 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methanocarba cycloalkyl nucleoside analogues
US8518957B2 (en) 2009-12-02 2013-08-27 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methanocarba adenosine derivatives, pharmaceutical compositions, and method of reducing intraocular pressure

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325505A (en) * 1965-02-24 1967-06-13 Smith Kline French Lab 4-cycloalkyl(or cycloalkenyl)-dihydropyridines
US3441648A (en) * 1967-02-07 1969-04-29 Smithkline Corp Compositions and methods for lowering blood pressure with 1,4-dihydropyridines
US3511847A (en) * 1967-02-07 1970-05-12 Smithkline Corp 2,6-di-lower alkyl - 1,4-dihydro - 4-(2-trifluoromethylphenyl) - 3,5 - pyridinedicarboxylic acid esters
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
US3455945A (en) * 1967-06-07 1969-07-15 Smithkline Corp 4-(carboxy (and carbo-lower alkoxy)phenyl)-1,4-dihydropyridines
US3455939A (en) * 1967-06-07 1969-07-15 Smithkline Corp 4-(4-chloro-3-sulfamoylphenyl)-1,4-dihydropyridines
DE1813436C3 (de) * 1968-12-07 1979-01-11 Bayer Ag, 5090 Leverkusen N-Substituierte 2,6-Dimethyl-l,4dihydropyridine
DE2013431C3 (de) * 1970-03-20 1979-12-20 Bayer Ag, 5090 Leverkusen 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester
DE1963188A1 (de) * 1969-12-17 1971-06-24 Bayer Ag Neue Cyanphenyl-1,4-dihydropyridinderivate
DE1963186C3 (de) * 1969-12-17 1979-02-15 Bayer Ag, 5090 Leverkusen Schwefelhaltige 1,4-Dihydropyridin-33-dicarbonsäureester

Also Published As

Publication number Publication date
BE762580A (fr) 1971-08-05
DK135282C (da) 1977-08-15
NL171580C (nl) 1983-04-18
CS161771B2 (ja) 1975-06-10
FR2150555A1 (ja) 1973-04-13
NL171580B (nl) 1982-11-16
AT302302B (de) 1972-10-10
YU18471A (en) 1978-12-31
DE2005116C3 (de) 1980-02-14
ES387973A1 (es) 1974-01-16
CH553780A (de) 1974-09-13
US4048171A (en) 1977-09-13
CA944768A (en) 1974-04-02
GB1326491A (en) 1973-08-15
IE34896B1 (en) 1975-09-17
GB1328479A (en) 1973-08-30
DK135282B (da) 1977-03-28
JPS5550021B1 (ja) 1980-12-16
DE2005116B2 (de) 1979-06-07
FR2150555B1 (ja) 1974-09-06
NL7101234A (ja) 1971-08-09
IL36018A0 (en) 1971-03-24
DE2005116A1 (de) 1971-09-02
IE34896L (en) 1971-08-05

Similar Documents

Publication Publication Date Title
ZA71438B (en) New 1,4-dihydropyridine derivatives
ZA711597B (en) 1,4-dihydropyridine derivatives
IL37825A (en) 1-phenyl-8-chloro-2,3,4-5-tetrahydro-1h-1,5-benzodiazepin-2-one derivatives
AU470566B2 (en) 3, 5-dioxopiperazine derivatives
ZA711602B (en) 3,4-dihydroisoquinoline derivatives
ZA707820B (en) New cyanophenyl-1,4-dihydropyridine derivatives
HK78076A (en) 2,2-diaryl-4-(4-aryl-4-hydroxy-piperidino)-butyramides
ZA712312B (en) 4,14-estradiene compounds
AU465145B2 (en) 2, 4-diamino-5-benzylpyrimidines
CA928710A (en) 1,2,3,4-tetrahydroisoquinoline derivatives
PH12851A (en) 1,2,3,4,5,6-hekahydro-1-oxo-2,6-methano-benzazocines
AU456846B2 (en) New 1, 4 dihydropyridine derivatives
IL37724A (en) N-substituted-2,3-dihydro-2-oxo-5-phenyl-1h 1,4-benzodiazepine-1-carboxamides
IL37771A0 (en) 1,4-benzodioxanes
PH9363A (en) 5,6-trans-prostaglandins
AU449559B2 (en) 1, 4 dihydropyridine derivatives
CA837636A (en) 1,3-diazacyclo-2,4-butanediones
AU2468271A (en) New 1, 4 dihydropyridine derivatives
IE34884B1 (en) 1,2,3-trithiane derivatives
PH9684A (en) 2,6-dinitroanilin derivatives
AU2666971A (en) 1, 4 dihydropyridine derivatives
ZA711839B (en) 1,2,4-oxadiazoline derivatives
ZA71927B (en) Derivatives of 1,2-diphenyl-ethane
IL38791A0 (en) 2,3-benzoxazepine derivatives
AU3151271A (en) Substituted 1, 3-indandiols